Published :
Tables : 58
Figures : 51
Category : Healthcare
No. of Pages : 246
Report Code : HC-U5333
Maternal Health Market is poised to register a CAGR of 9% during the forecast period 2022 to 2028. FutureWise Market Research has instantiated Risks in Pregnancyreport that provides an intricate analysis of Maternal Health Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Health Information Exchange Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical. Major players included in the Maternal Health Market: • Agile Therapeutics (USA) • Fuji Latex Co (Japan) • Okamoto industries • Reckitt Benckiser Group Plc.(UK) • Sanofi (India) • Johnson and Johnson(USA) • McKinsey & Company • MedTech Boston • Merck Sharp & Dohme Corp. • RAND Corporation (Note: The list of the major players will be updated with the latest market scenario and trends) Maternal Health Market Segmentation: By Type of Pregnancy • Intrauterine • Ectopic • Tubal • Others By Risks in Pregnancy • High • Molar By Complications • Miscarriage o Threatened o Inevitable o Complete o Incomplete • Premature Labor and Birth • Preeclampsia • Gestational Diabetes • Placenta Previa • Others By Delivery Type • Vaginal Delivery • Cesarian Section • Vacuum Extraction • Forceps Delivery By Care • Pre Natal care • Post Natal Care By Drug Class • Hormones • Nutritives • Analgesics • Anti-infectives • Other By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth Objectives of the Study: • To provide with an exhaustive analysis on the Maternal Health Market By Type of Pregnancy, By Risks in Pregnancy, By Complications, By Delivery Type, By Care, By Drug Class and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
FutureWise Market Research has instantiated Risks in Pregnancyreport that provides an intricate analysis of Maternal Health Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market. According to the research study conducted by FutureWise research analysts, the Health Information Exchange Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.
Major players included in the Maternal Health Market: • Agile Therapeutics (USA) • Fuji Latex Co (Japan) • Okamoto industries • Reckitt Benckiser Group Plc.(UK) • Sanofi (India) • Johnson and Johnson(USA) • McKinsey & Company • MedTech Boston • Merck Sharp & Dohme Corp. • RAND Corporation (Note: The list of the major players will be updated with the latest market scenario and trends)
Maternal Health Market Segmentation: By Type of Pregnancy • Intrauterine • Ectopic • Tubal • Others
By Risks in Pregnancy • High • Molar
By Complications • Miscarriage o Threatened o Inevitable o Complete o Incomplete • Premature Labor and Birth • Preeclampsia • Gestational Diabetes • Placenta Previa • Others
By Delivery Type • Vaginal Delivery • Cesarian Section • Vacuum Extraction • Forceps Delivery
By Care • Pre Natal care • Post Natal Care
By Drug Class • Hormones • Nutritives • Analgesics • Anti-infectives • Other
By Region • North America • Europe • Asia-Pacific • Latin America • Middle East and Africa
Competitive Landscape: • Tier 1 players- established companies in the market with a major market share • Tier 2 players • Emerging players which are growing rapidly • New Entrants
FutureWise Key Takeaways: • Growth prospects • SWOT analysis • Key trends • Key data-points affecting market growth
Objectives of the Study: • To provide with an exhaustive analysis on the Maternal Health Market By Type of Pregnancy, By Risks in Pregnancy, By Complications, By Delivery Type, By Care, By Drug Class and By Region. • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) • To evaluate and forecast micro-markets and the overall market • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Flexible Delivery Model: • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement • The customization Mobility Care offered are free of charge with purchase of any license of the report • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global Health Information Exchange Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances 5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Health Information Exchange Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global Health Information Exchange Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Maternal Health Market, By Type of Pregnancy Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Intrauterine 7.2. Ectopic 7.3. Tubal 7.4. Others 8. Maternal Health Market, By Risks in Pregnancy Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. High 8.2. Molar 9. Maternal Health Market, By Complications Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Miscarriage 9.1.1. Threatened 9.1.2. Inevitable 9.1.3. Complete 9.1.4. Incomplete 9.2. Premature Labor and Birth 9.3. Preeclampsia 9.4. Gestational Diabetes 9.5. Placenta Previa 9.6. Others 10. Maternal Health Market, By Delivery Type Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Vaginal Delivery 10.2. Cesarian Section 10.3. Vacuum Extraction 10.4. Forceps Delivery 11. Maternal Health Market, By Care Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Pre Natal care 11.2. Post Natal Care 12. Maternal Health Market, By Drug Class Historical Analysis and Forecast 2022-2028 (USD Million) 12.1. Hormones 12.2. Nutritives 12.3. Analgesics 12.4. Anti-infectives 12.5. Other 13. North America Health Information Exchange Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. U.S.A 13.2.2. Canada 13.2.3. Mexico 13.3. Market Size (USD Million) Forecast for North America 2022-2028 14. Latin America Health Information Exchange Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Brazil 14.2.2. Venezuela 14.2.3. Argentina 14.2.4. Rest of Latin America 14.3. Market Size (USD Million) Forecast for Latin America 2022-2028 15. Europe Health Information Exchange Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Germany 15.2.2. U.K 15.2.3. France 15.2.4. Italy 15.2.5. Spain 15.2.6. Russia 15.2.7. Poland 15.2.8. Rest of Europe 15.3. Market Size (USD Million) Forecast for Europe 2022-2028 16. Asia Pacific Health Information Exchange Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Japan 16.2.2. China 16.2.3. India 16.2.4. Australia and New Zealand 16.2.5. ASEAN 16.2.6. Rest of Asia Pacific 16.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028 17. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 17.2.1. GCC 17.2.2. Israel 17.2.3. South Africa 17.2.4. Rest of MEA 17.3. Market Size (USD Million) Forecast for MEA 2022-2028 18. Market Share Analysis and Competitive Landscape 18.1. Global Landscape - Key Players, Revenue and Presence 18.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 18.3. Global Emerging Companies 18.4. North America - Market Share Analysis and Key Regional Players 18.5. Europe - Market Share Analysis and Key Regional Players 18.6. Asia Pacific - Market Share Analysis and Key Regional Players 18.7. Global Key Player - Growth Matrix 19. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 19.1. Agile Therapeutics (USA) 19.1.1. Company Overview 19.1.2. Product Portfolio 19.1.3. SWOT Analysis 19.1.4. Financial Overview 19.1.5. Strategic Overview 19.2. Fuji Latex Co (Japan) 19.2.1. Company Overview 19.2.2. Product Portfolio 19.2.3. SWOT Analysis 19.2.4. Financial Overview 19.2.5. Strategic Overview 19.3. Okamoto industries 19.3.1. Company Overview 19.3.2. Product Portfolio 19.3.3. SWOT Analysis 19.3.4. Financial Overview 19.3.5. Strategic Overview 19.4. Reckitt Benckiser Group Plc.(UK) 19.4.1. Company Overview 19.4.2. Product Portfolio 19.4.3. SWOT Analysis 19.4.4. Financial Overview 19.4.5. Strategic Overview 19.5. Sanofi (India) 19.5.1. Company Overview 19.5.2. Product Portfolio 19.5.3. SWOT Analysis 19.5.4. Financial Overview 19.5.5. Strategic Overview 19.6. Johnson and Johnson(USA) 19.6.1. Company Overview 19.6.2. Product Portfolio 19.6.3. SWOT Analysis 19.6.4. Financial Overview 19.6.5. Strategic Overview 19.7. McKinsey & Company 19.7.1. Company Overview 19.7.2. Product Portfolio 19.7.3. SWOT Analysis 19.7.4. Financial Overview 19.7.5. Strategic Overview 19.8. MedTech Boston 19.8.1. Company Overview 19.8.2. Product Portfolio 19.8.3. SWOT Analysis 19.8.4. Financial Overview 19.8.5. Strategic Overview 19.9. Merck Sharp & Dohme Corp. 19.9.1. Company Overview 19.9.2. Product Portfolio 19.9.3. SWOT Analysis 19.9.4. Financial Overview 19.9.5. Strategic Overview 19.10. RAND Corporation 19.10.1. Company Overview 19.10.2. Product Portfolio 19.10.3. SWOT Analysis 19.10.4. Financial Overview 19.10.5. Strategic Overview 20. Pre and Post COVID-19 Impact 20.1. Positive influence on the healthcare industry 20.2. The financial disruption of the manufacturing sector 20.3. Impact of COVID-19 on emerging companies 20.4. Significant mandates in the healthcare regulations initiated by administrations 20.5. The overall economic slowdown of the developing and developed nations 21. FutureWise SME Key Takeaway Points for Client
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders
2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data from Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data from Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study
3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights
4. Global Health Information Exchange Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards and Compliances
5. Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of Health Information Exchange Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global Health Information Exchange Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies
7. Maternal Health Market, By Type of Pregnancy Historical Analysis and Forecast 2022-2028 (USD Million) 7.1. Intrauterine 7.2. Ectopic 7.3. Tubal 7.4. Others
8. Maternal Health Market, By Risks in Pregnancy Historical Analysis and Forecast 2022-2028 (USD Million) 8.1. High 8.2. Molar
9. Maternal Health Market, By Complications Historical Analysis and Forecast 2022-2028 (USD Million) 9.1. Miscarriage 9.1.1. Threatened 9.1.2. Inevitable 9.1.3. Complete 9.1.4. Incomplete 9.2. Premature Labor and Birth 9.3. Preeclampsia 9.4. Gestational Diabetes 9.5. Placenta Previa 9.6. Others
10. Maternal Health Market, By Delivery Type Historical Analysis and Forecast 2022-2028 (USD Million) 10.1. Vaginal Delivery 10.2. Cesarian Section 10.3. Vacuum Extraction 10.4. Forceps Delivery
11. Maternal Health Market, By Care Historical Analysis and Forecast 2022-2028 (USD Million) 11.1. Pre Natal care 11.2. Post Natal Care
12. Maternal Health Market, By Drug Class Historical Analysis and Forecast 2022-2028 (USD Million) 12.1. Hormones 12.2. Nutritives 12.3. Analgesics 12.4. Anti-infectives 12.5. Other
13. North America Health Information Exchange Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 13.2.1. U.S.A 13.2.2. Canada 13.2.3. Mexico 13.3. Market Size (USD Million) Forecast for North America 2022-2028
14. Latin America Health Information Exchange Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 14.2.1. Brazil 14.2.2. Venezuela 14.2.3. Argentina 14.2.4. Rest of Latin America 14.3. Market Size (USD Million) Forecast for Latin America 2022-2028
15. Europe Health Information Exchange Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 15.1. Introduction 15.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 15.2.1. Germany 15.2.2. U.K 15.2.3. France 15.2.4. Italy 15.2.5. Spain 15.2.6. Russia 15.2.7. Poland 15.2.8. Rest of Europe 15.3. Market Size (USD Million) Forecast for Europe 2022-2028
16. Asia Pacific Health Information Exchange Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 16.1. Introduction 16.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 16.2.1. Japan 16.2.2. China 16.2.3. India 16.2.4. Australia and New Zealand 16.2.5. ASEAN 16.2.6. Rest of Asia Pacific 16.3. Market Size (USD Million) Forecast for Asia Pacific 2022-2028
17. Middle East and Africa Market Analysis 2016–2020 and Forecast 2022–2028 (USD Million) 17.1. Introduction 17.2. Historical Market Size (USD Million) Analysis By Country, 2016-2020 17.2.1. GCC 17.2.2. Israel 17.2.3. South Africa 17.2.4. Rest of MEA 17.3. Market Size (USD Million) Forecast for MEA 2022-2028
18. Market Share Analysis and Competitive Landscape 18.1. Global Landscape - Key Players, Revenue and Presence 18.2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3) 18.3. Global Emerging Companies 18.4. North America - Market Share Analysis and Key Regional Players 18.5. Europe - Market Share Analysis and Key Regional Players 18.6. Asia Pacific - Market Share Analysis and Key Regional Players 18.7. Global Key Player - Growth Matrix
19. Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts) 19.1. Agile Therapeutics (USA) 19.1.1. Company Overview 19.1.2. Product Portfolio 19.1.3. SWOT Analysis 19.1.4. Financial Overview 19.1.5. Strategic Overview 19.2. Fuji Latex Co (Japan) 19.2.1. Company Overview 19.2.2. Product Portfolio 19.2.3. SWOT Analysis 19.2.4. Financial Overview 19.2.5. Strategic Overview 19.3. Okamoto industries 19.3.1. Company Overview 19.3.2. Product Portfolio 19.3.3. SWOT Analysis 19.3.4. Financial Overview 19.3.5. Strategic Overview 19.4. Reckitt Benckiser Group Plc.(UK) 19.4.1. Company Overview 19.4.2. Product Portfolio 19.4.3. SWOT Analysis 19.4.4. Financial Overview 19.4.5. Strategic Overview 19.5. Sanofi (India) 19.5.1. Company Overview 19.5.2. Product Portfolio 19.5.3. SWOT Analysis 19.5.4. Financial Overview 19.5.5. Strategic Overview 19.6. Johnson and Johnson(USA) 19.6.1. Company Overview 19.6.2. Product Portfolio 19.6.3. SWOT Analysis 19.6.4. Financial Overview 19.6.5. Strategic Overview 19.7. McKinsey & Company 19.7.1. Company Overview 19.7.2. Product Portfolio 19.7.3. SWOT Analysis 19.7.4. Financial Overview 19.7.5. Strategic Overview 19.8. MedTech Boston 19.8.1. Company Overview 19.8.2. Product Portfolio 19.8.3. SWOT Analysis 19.8.4. Financial Overview 19.8.5. Strategic Overview 19.9. Merck Sharp & Dohme Corp. 19.9.1. Company Overview 19.9.2. Product Portfolio 19.9.3. SWOT Analysis 19.9.4. Financial Overview 19.9.5. Strategic Overview 19.10. RAND Corporation 19.10.1. Company Overview 19.10.2. Product Portfolio 19.10.3. SWOT Analysis 19.10.4. Financial Overview 19.10.5. Strategic Overview
20. Pre and Post COVID-19 Impact 20.1. Positive influence on the healthcare industry 20.2. The financial disruption of the manufacturing sector 20.3. Impact of COVID-19 on emerging companies 20.4. Significant mandates in the healthcare regulations initiated by administrations 20.5. The overall economic slowdown of the developing and developed nations
21. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics